首页|中西医结合治疗青春期多囊卵巢综合征疗效的Meta分析

中西医结合治疗青春期多囊卵巢综合征疗效的Meta分析

扫码查看
目的:本研究系统评价中西医结合治疗青春期多囊卵巢综合征(Polycystic Ovary Syndrome,PCOS)的疗效及安全性,为诊治青春期PCOS的临床实践研究提供循证医学依据.方法:计算机检索中国知网、PubMed、The Cochrane Library、Embase、万方、CQVIP等数据库,收集从建库至2022年12月公开发表的有关中西医结合治疗青春期PCOS的随机对照试验(Randomized Controlled Trial,RCT).对文献进行筛选后,采用Cochrane风险偏倚评估工具对原始研究进行质量评估,采用RevMan 5.3软件进行Meta数据分析.结果:共有18篇RCT研究,涉及1 349例患者,其中试验组(中西医联合治疗)675例、对照组(单用西药治疗)674例.Meta分析发现:试验组疗效优于对照组[优势比(OR)=4.19,95%置信区间(CI)(3.00,5.84),P<0.000 01],与单用西药组相比,试验组可有效降低青春期PCOS患者的促黄体生成素(LuteinizingHormone,LH)水平[标准化均数差(SMD)=-1.15,95%CI(-1.64,-0.66),P<0.000 01]、LH/促卵泡生成素(Follicle-stimulating Hormone,FSH)水平[SMD=-1.15,95%CI(-1.64,-0.66),P<0.000 01]、雄激素睾酮(Testosterone,T)水平[SMD=-0.97,95%CI(-1.45,-0.49),P<0.000 1]、胰岛素抵抗指数(Homa Insulin-resistance,HOMA-IR)水平[MD=-0.66,95%CI(-1.20,-0.12),P=0.02]及空腹胰岛素(Fasting Insulin,FINS)水平[MD=-1.72,95%CI(-2.44,-0.99),P<0.000 01],可降低体质量指数(Body Mass Index,BMI)[MD=-1.47,95%CI(-2.51,-0.44),P=0.005]以及青春期PCOS患者的痤疮体征评分[MD=-0.70,95%CI(-0.94,-0.47),P<0.000 01]和中医临床症状积分[MD=-2.53,95%CI(-3.25,-1.80),P<0.000 01],有效减小卵巢体积[MD=-1.36,95%CI(-1.99,-0.74),P<0.000 1]以及减少卵泡数目[MD=-1.58,95%CI(-2.74,-0.42),P=0.008].但两组在 FSH 水平[SMD=-0.36,95%CI(-1.33,0.41),P=0.36]、空腹血糖(Glucose,GLU)水平[MD=-0.22,95%CI(-0.59,0.16),P=0.26]和雌二醇(Estradio,E2)水平[SMD=0.17,95%CI(-0.23,0.57),P=0.41]及不良反应[RR=-0.51,95%CI(0.26,1.01),P=0.05]上差异无统计学意义.结论:中西医结合治疗青春期PCOS的临床疗效优于单纯采用西药.
A Meta-analysis of the curative effect of the integrative medicine on adolescent polycystic ovary syndrome
Objective:This study systematically evaluates the efficacy and safety of the integrative medicine in the treatment of ado-lescent PCOS,in order to provide evidence-based medical evidence for the clinical practice of diagnosis and treatment of adolescent PCOS.Methods:Chinese National Knowledge Infrastructure(CNKI),PubMed,The Cochrane Library,Embase,WANGFANG,CQVIP and other databases were searched by computer to collect the randomized controlled trials(RCTS)on the treatment of adolescent poly-cystic ovary syndrome in the integrative medicine published from the establishment of the database to December 2022.After literature screening,Cochrane risk bias assessment tool was used to evaluate the quality of the original study,and Meta-analysis was performed using RevMan 5.3 software.Results:A total of 18 RCTS,involving 1 349 patients were included in the study,including 675 cases in the crial group(took the treat-ment of the integrative medicine)and 674 cases in the control group(Western medicine alone).Meta-analysis revealed that the efficacy in the experimental group was better than the control group[OR=4.19,95%CI(3.00,5.84),P<0.000 01].Compared with the Western medicine group,the crial group effectively reduced LH level[SMD=-1.15,95%CI(-1.64,-0.66),P<0.000 01],LH/FSH level[SMD=-1.15,95%CI(-1.64,-0.66),P<0.000 01],T level[SMD=-0.97,95%CI(-1.45,-0.49),P<0.000 1],HOMA-IR level[MD=-0.66,95%CI(-1.20,-0.12),P=0.02]and FINS level[MD=-1.72,95%CI(-2.44,-0.99),P<0.000 01],decreased BMI[MD=-1.47,95%CI(-2.51,-0.44),P=0.005],reduced acne sign scores[MD=-0.70,95%CI(-0.94,-0.47),P<0.000 01]and TCM clinical symptom scores[MD=-2.53,95%CI(-3.25,-1.80),P<0.000 01],which effectively reduced ovarian volume[MD=-1.36,95%CI(-1.99,-0.74),P<0.000 1],and follicle number[MD=-1.58,95%CI(-2.74,-0.42),P=0.008]in adolescent PCOS patients.However,the two groups showed a decrease no statistically significant difference in FSH level[SMD=-0.36,95%CI(-1.33,0.41),P=0.36],GLU level[MD=-0.22,95%CI(-0.59,0.16),P=0.26]and E2 level[SMD=0.17,95%CI(-0.23,0.57),P=0.41],and adverse reactions[RR=-0.51,95%CI(0.26,1.01),P=0.05].Conclusion:The clinical effica-cy of integrated Chinese and western medicine is better than that of Western medicine alone in the treatment of adolescent polycystic ovary syndrome.

Adolescent polycystic ovary syndromeThe integrative medicineMeta-analysis

代杨、韩亚光、朱小琳、高艺媛

展开 >

黑龙江中医药大学,黑龙江 哈尔滨,150006

黑龙江中医药大学附属第一医院,黑龙江 哈尔滨,150040

黑龙江中医药大学附属第二医院,黑龙江 哈尔滨,150001

青春期多囊卵巢综合征 中西医结合 Meta分析

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(24)